TLRY Tilray

Breckenridge Distillery Announces Re-Release of Award-Winning Cognac Cask Finish Whiskey

Breckenridge Distillery Announces Re-Release of Award-Winning Cognac Cask Finish Whiskey

Following a limited release in 2022 for the Collectors Art Series, Breckenridge Cognac Cask Finish Whiskey is now a permanent addition to the cask finish line

BRECKENRIDGE, Colo., April 23, 2025 (GLOBE NEWSWIRE) -- , one of the most-awarded craft distilleries in the U.S., and a Tilray Brands, Inc., (NASDAQ: TLRY and TSX: TLRY) spirits brand, today announced its newest addition to the brand’s line of cask finish whiskeys, Breckenridge Cognac Cask Finish. Initially launched as a limited edition in the second at the distillery's Breckenridge location in 2022, this whiskey is now available in Colorado with national expansion planned in the coming months.



Photo Courtesy: Jessie Unruh, Breckenridge Distillery

Cognac is produced with well-known grapes from regions in France. A fine Cognac is 15 percent Petite Champagne and 85 percent Grande Champagne, typically blended in batches of 300 barrels and aged anywhere from 10-37 years. Breckenridge Distillery imported its barrels and aged its Breckenridge Bourbon Whiskey in Cognac barrels for over two years. The Cognac label features the iris, France's national flower, and grape blossoms, nodding to the grape's origin.

Breckenridge Cognac Cask Finish Whiskey is 96 proof, with tasting notes of sweet red apple and a delicate balance of brandied fruit and caramel with an over-ripe apple sweetness and bourbon rye spice. The cask finish whiskey will be bottled and retail for $59.99 SRP.

“Our Cognac Cask Finish is a testament to our dedication to innovation and quality,” said Bryan Nolt, Founder and CEO at Breckenridge Distillery. “Cask finishes have become integral to our business and are among our most beloved and award-winning whiskeys. We are proud to reintroduce this exceptional whiskey to our collection, crafted with the same passion and precision that defines all our spirits.”

The limited-edition Breckenridge Cognac Cask Finish won Gold at the World Whiskies Awards for Best American Blended Limited Release, Double Gold at the 2023 San Francisco World Spirits Competition, and 95 points at the 2023 New York International Spirits Competition. The Collectors Art Series Campaign was named the 2020 Icon of Whisky for Campaign Innovator of the Year.

For more information about Breckenridge Distillery and to purchase the new Breckenridge Cognac Cask Finish Whiskey, visit Follow Breckenridge on Instagram and become a fan at Age 21+. Always enjoy responsibly.

About Breckenridge Distillery



Founded in Colorado in 2008, Breckenridge Distillery is the “World’s Highest Distillery,” and is best known for its award-winning blended bourbon whiskey, a high-rye mash American-style whiskey.

One of the most highly awarded distilleries in the U.S., the Breckenridge Distillery is proudly a 3x Icons of Whisky and 10x winner of Best American Blended winner at the World Whiskies Awards by Whisky Magazine and a 4x winner of Colorado Distillery of the Year by the New York International Spirits Competition. Most recently, Breckenridge Port Cask Finish was named World’s Best Finished Bourbon at the 2024 World Whiskies Awards, joining Breckenridge High Proof, named World’s Best Blended Whiskey and Breckenridge Gin, named World’s Best Compound Gin at the World Gin Awards by Gin Magazine. Breckenridge spirits have been awarded 6 Double Golds at the San Francisco World Spirits Competition.

The Breckenridge Distillery is more than award-winning spirits, offering an immersive guest experience. Named as one of the country’s Top Visitor Attractions by Whisky Magazine, guests can dine at their award-winning restaurant, enjoy show-stopping cocktails, learn about their highly awarded spirits with an in-depth tasting, and get an inside look at their active production facility. New to the distillery, guests have the opportunity to blend their own whiskey as they learn the inner workings of whiskey production.

Breckenridge Distillery is a subsidiary of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company inspiring and empowering the worldwide community to live their very best life.

To learn more about Breckenridge Distillery, visit . Keep up with Breckenridge Distillery on Instagram by following and become a fan at

For more information about Tilray Brands, visit  and follow @tilray on Instagram, Twitter, Facebook, and LinkedIn.

Forward-Looking Statements



Certain statements in this communication that are not historical facts constitute forward-looking information or forward-looking statements (together, “forward-looking statements”) under Canadian and U.S. securities laws and within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be subject to the “safe harbor” created by those sections and other applicable laws. Forward-looking statements can be identified by words such as “forecast,” “future,” “should,” “could,” “enable,” “potential,” “contemplate,” “believe,” “anticipate,” “estimate,” “plan,” “expect,” “intend,” “may,” “project,” “will,” “would” and the negative of these terms or similar expressions, although not all forward-looking statements contain these identifying words. Certain material factors, estimates, goals, projections, or assumptions were used in drawing the conclusions contained in the forward-looking statements throughout this communication. Forward-looking statements include statements regarding our intentions, beliefs, projections, outlook, analyses, or current expectations. Many factors could cause actual results, performance, or achievement to be materially different from any forward-looking statements, and other risks and uncertainties not presently known to the Company or that the Company deems immaterial could also cause actual results or events to differ materially from those expressed in the forward-looking statements contained herein. For a more detailed discussion of these risks and other factors, see the most recently filed annual information form of Tilray and the Annual Report on Form 10-K (and other periodic reports filed with the SEC) of Tilray made with the SEC and available on EDGAR. The forward-looking statements included in this communication are made as of the date of this communication and the Company does not undertake any obligation to publicly update such forward-looking statements to reflect new information, subsequent events, or otherwise unless required by applicable securities laws. 

For media inquiries, please contact:

Tilray Brands Media:

Investors:

A photo accompanying this announcement is available at



EN
23/04/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Tilray

 PRESS RELEASE

Tilray Brands Acquires BrewDog, a Leading Global Craft Brand, Creating...

Tilray Brands Acquires BrewDog, a Leading Global Craft Brand, Creating a ~$500 Million Global Craft Beer and Beverage Platform Accretive Acquisition of Select Assets Includes Global Brand, UK Brewing Operations and 11 Strategic Brewpubs  Expected to Generate ~$200 Million in Annual Net Revenue and ~$6 - $8 Million of Adjusted EBITDA in Fiscal 2027 Tilray’s Global Consolidated Net Revenue Expected to Reach ~$1.2 Billion on an Annualized Basis1 Conference Call Scheduled for 12:30pm ET NEW YORK and LONDON, March 02, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray”, “our”, “we” or t...

 PRESS RELEASE

Good Supply Cannabis Brand Expands High-Potency Portfolio with New Spr...

Good Supply Cannabis Brand Expands High-Potency Portfolio with New Spring Lineup Across Canada Seasonal Innovation Strengthens Good Supply’s Position in Vape and Pre-roll Formats, Supporting Continued Retail Momentum and Consumer Demand TORONTO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the cannabis, beverage and wellness industries, today announced that Good Supply, one of Canada’s most recognized cannabis brands, has launched its spring product lineup, a new seasonal product release designed...

 PRESS RELEASE

Tilray Brands and the Carlsberg Group Enter into an Exclusive Multi-Ye...

Tilray Brands and the Carlsberg Group Enter into an Exclusive Multi-Year U.S. Brewing and Commercial Partnership NEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (NASDAQ: TLRY; TSX: TLRY), a leading global consumer packaged goods company and the fourth-largest craft beer brewer in the United States, today announced that it has entered into an exclusive licensing agreement starting January 1, 2027 with the Carlsberg Group, one of the world’s premier brewing organizations and among the largest globally by revenue. Under the terms of the agreement, Tilray has been granted a m...

 PRESS RELEASE

Tilray erweitert den pharmazeutischen Zugang im Vereinigten Königreich...

Tilray erweitert den pharmazeutischen Zugang im Vereinigten Königreich durch eine strategische Vereinbarung mit Smartway Pharmaceuticals CC-Pharma-Vereinbarung fördert das Wachstum von Tilray im Vereinigten Königreich und stärkt den Vertrieb über Apotheken- und Krankenhauskanäle NEW YORK und LONDON, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Tilray Pharma, die Pharmasparte von Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), gab heute bekannt, dass ihr europäisches pharmazeutisches Vertriebsunternehmen CC Pharma eine strategische Vereinbarung mit , einem führenden pharmazeutischen Vertriebspartner...

 PRESS RELEASE

Tilray élargit son accès aux produits pharmaceutiques au Royaume-Uni g...

Tilray élargit son accès aux produits pharmaceutiques au Royaume-Uni grâce à un accord stratégique avec Smartway Pharmaceuticals L’accord avec CC Pharma renforce la croissance de Tilray au Royaume-Uni, consolidant sa distribution auprès des pharmacies et des hôpitaux NEW YORK et LONDRES, 13 févr. 2026 (GLOBE NEWSWIRE) -- Tilray Pharma, la division pharmaceutique de Tilray Brands, Inc. (Nasdaq : TLRY ; TSX : TLRY), a annoncé aujourd'hui que son activité de distribution pharmaceutique européenne, CC Pharma, a conclu un accord stratégique avec , un partenaire de distribution pharmaceutique...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch